Back to Authors

Lawendy, Bishoy

https://orcid.org/0000-0002-0447-3871

Mayo Clinic

Western University

Citations 6

S2030 The Prevalence of Low Fecal Elastase Among Patients With Pancreatic Adenocarcinoma
Ogbu, Chukwuemeka E. , Ezeani, Chukwunonso , Lawendy, Bishoy , Bhatti, Tayyaba, Babajide, Oyedotun , Adekunle, Deborah, Okafor, Philip N. , Youssef, Michael, Osagiede, Osayande

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S1451-S1453

10.14309/01.ajg.0001037488.46148.4e Get It

S932 Outcomes of Endoscopic Procedures in Patients With High-Risk Cardio-Pulmonary Disease: A Population-Based Study
Ezeani, Chukwunonso , Babajide, Oyedotun , Ogbu, Chukwuemeka E. , Lawendy, Bishoy , Adekunle, Deborah, Okafor, Philip N. , Youssef, Michael, Rubens, Muni

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S652-S652

10.14309/01.ajg.0001033096.05449.cc Get It

A99 HIGHER HOSPITAL INPATIENT RACIAL DIVERSITY IS ASSOCIATED WITH BETTER OUTCOMES AMONG HISPANIC AND INDIGENOUS AMERICAN PATIENTS FOR FIVE COMMON GASTROINTESTINAL DIAGNOSES
Lawendy, Bishoy , Sedarous, Mary , Babajide, O, Adekunle, A O, Okafor, Philip N. , Sedarous, Mary , Babajide, Oyedotun , Adekunle, A, Rubens, Muni

Journal of the Canadian Association of Gastroenterology | February 16, 2024 | Volume: 7 | Issue: Supplement_1 | Pages: 71-72

10.1093/jcag/gwad061.099 Get It

Abstract Background There is evidence that gastrointestinal disease (GI) outcomes are poorer among patients from underrepresented backgrounds. However, the impact of hospital patient racial diversity on GI outcomes is understudied. Aims We aimed to investigate the impact of hospital patient racial diversity on GI outcomes Methods Using the 2019 National Inpatient Sample (NIS), racial diversity was defined by the percentage of Hispanic or Indigenous American patients discharged from each hospital. GI discharge diagnoses were defined by diagnostic related group. We included GI bleeding, inflammatory bowel diseases, GI obstruction, cirrhosis, and alcoholic hepatitis. Logistic regression was used to predict major complication rates or comorbidity (MCC), long length of stay (LOS), and high total charges. Control variables included age, gender, payer type, patient location, area-associated income quartile, hospital characteristics including size, urban vs. rural, teaching vs. nonteaching, region, and the interaction of the percentage of Hispanic and Indigenous Americans with patient race. Results were validated with the 2018 NIS dataset. Results Our analysis cohort of 537,830 hospitalizations included 252,225 GI bleeding discharges, 59,310 gastrointestinal obstruction discharges, 106,820 cirrhosis and alcoholic hepatitis discharges, and 119,475 inflammatory bowel diseases discharges. In the unadjusted analyses, MCC rates were higher among Hispanic (24.8%) and Indigenous American patients (30.4%), compared to Whites (18.3%). In adjusted analyses, compared to white patients, Hispanic patients had higher MCC rates [adjusted odds ratio (OR) 1.21, 95% Confidence Interval (CI) 1.15-1.28]. The same trend was seen among Indigenous American patients [OR 1.25, (95% CI) 1.09-1.43]. However, as hospital Hispanic diversity increased, inpatient MCC outcomes for Hispanics improved [OR 0.93, (95% CI) 0.87-1.14], and were even better among Indigenous American patients as hospital inpatient Indigenous American diversity increased [OR 0.83, (95% CI) 0.73-0.94] (Table 1). A similar improvement in MCC with increasing Hispanic and Indigenous American diversity was observed in the 2018 validation cohort. Table 1 highlights impact of increasing diversity on LOS and total charges. Conclusions Increasing hospital inpatient Hispanic and Indigenous American diversity is associated with better outcomes for these underrepresented minority groups. More research is needed on the impact of cultural competence and linguistic concordance on patient outcomes. Funding Agencies None
S91 Risk of Pancreatic Adenocarcinoma in Patients on Oral Hypoglycemic Agents for Type 2 Diabetes Mellitus
Babajide, Oyedotun , Adekunle, Ayooluwatomiwa D. , Youssef, Michael , Sedarous, Mary , Lawendy, Bishoy , Okafor, Philip N. , Desai, Aakash , Sedarous, Mary

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S73-S74

10.14309/01.ajg.0000950004.68230.50 Get It

S90 New-Onset Diabetes Mellitus and the Risk of Pancreatic Adenocarcinoma: A Propensity Matched Population-Level Study Using Hemoglobin A1c
Babajide, Oyedotun , Adekunle, Ayooluwatomiwa D. , Youssef, Michael , Sedarous, Mary , Lawendy, Bishoy , Okafor, Philip N. , Desai, Aakash , Sedarous, Mary

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S73-S73

10.14309/01.ajg.0000950000.42463.09 Get It

Enteric dysbiosis in liver and kidney transplant recipients: a systematic review
Sivaraj, Saranya , Pasini, Elisa , Lawendy, Bishoy , Verna, Elizabeth C. , Watt, Kymberly D. , Bhat, Mamatha , Watt, Kymberly, Bhat, Mamatha , Chan, Anita, Chen, Emily

Transplant International | July 8, 2020 | Volume: 33 | Issue: 10 | Pages: 1163-1176

10.1111/tri.13696 Get It